On March 14, 2023, Institut Mérieux hosted a GeNeuro press conference on long-COVID, a major public health issue. Institut Mérieux is a reference shareholder of GeNeuro and follows with interest the development of this Franco-Swiss company, a bioMérieux spin-off created in 2006 by Dr. Perron, Dr. Christophe Mérieux and Jesùs Martin Garcia.
More info: GeNeuro – News & Media